NDMA is a probable human carcinogen, a substance that could cause cancer, the FDA said in April 2020, when the agency asked ...

This lawsuit concerns GSK’s fraud on the federal and state governments and the money spent on ranitidine products by governments because of that fraud. Whether ranitidine increases the risk of cancer ...

Per the FDA, research showed that the impurity in some ranitidine products increased over time and when the products were stored in higher-than-room-temperature conditions. “Low levels of NDMA ...

as well as other ranitidine products – increased the risk of cancer. Last May, Delaware judge Vivian Medinilla laid out a way forward to handle approximately 77,000 Zantac lawsuits filed in the ...

GSK to pay $70 million to settle whistleblower lawsuit Pfizer and Sanofi also settling Zantac cases Boehringer Ingelheim faces trial, denies wrongdoing Oct 9 (Reuters) - GSK (GSK.L), opens new tab ...

This came after studies revealed that ranitidine products might have unhealthy levels of NDMA, a known probable carcinogen that can lead to the development of cancer in users. While former Zantac ...

UK pharmaceutical giant GSK says it will pay as much as $2.2bn (£1.68bn) to settle thousands of cases in US courts over claims that a discontinued version of its heartburn drug Zantac caused cancer.